Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome.
A patient with an inferior vena cava thrombosis in nephrotic syndrome was treated with heparin, AT-III concentrates and urokinase. After a few days on treatment he showed a complete resolution of the thrombosis. We suggest that this therapeutic combination may be a good approach to the treatment of thrombosis in nephrotic syndrome.
Storti
S
S
Università Cattolica del Sacro Cuore, Rome, Italy.
Pagano
L
L
Marra
R
R
Grilli
A
A
Falappa
G
G
De Gaetano
A M
AM
Ferrante
A M
AM
Bizzi
B
B
D058186:Acute Kidney Injury / Q000150:complications; D000328:Adult; D000990:Antithrombin III / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications*; D011655:Pulmonary Embolism / Q000139:chemically induced; D015912:Thrombolytic Therapy / Q000009:adverse effects; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D014682:Vena Cava, Inferior
D000990:Antithrombin III; D014568:Urokinase-Type Plasminogen Activator